| UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses |
Globe Newswire |
03/09 |
08:30 |
| Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11 |
Globe Newswire |
03/09 |
08:30 |
| Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12 |
Globe Newswire |
03/09 |
08:30 |
| Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World |
Globe Newswire |
03/09 |
08:30 |
| Jeffs' Brands: KeepZone AI Enters into Channel Partner Agreement for 4G/5G Infrastructure |
Globe Newswire |
03/09 |
08:20 |
| Safe Harbor Financial CEO Highlights Growth Platform Launch, Debt Elimination, and Financial Stabilization in Letter to Shareholders |
Globe Newswire |
03/09 |
08:17 |
| Adeia Enters into Multi-Year IP License Agreement with AMD |
Globe Newswire |
03/09 |
08:06 |
| Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology |
Globe Newswire |
03/09 |
08:05 |
| AVAX One To Participate in the Digital Chamber’s DC Blockchain Summit 2026 |
Globe Newswire |
03/09 |
08:05 |
| Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease |
Globe Newswire |
03/09 |
08:05 |
| Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting |
Globe Newswire |
03/09 |
08:05 |
| Byrna Technologies Announces Preliminary Fiscal First Quarter Revenues of $29.0 Million |
Globe Newswire |
03/09 |
08:00 |
| Route 92 Medical Enrolls First Patient in SUMMIT RISE Study |
Globe Newswire |
03/09 |
08:00 |
| Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director and Provides Patent Portfolio Update for Texatron Fusion Platform |
Globe Newswire |
03/09 |
08:00 |
| Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 |
Globe Newswire |
03/09 |
08:00 |
| Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum |
Globe Newswire |
03/09 |
08:00 |
| MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism |
Globe Newswire |
03/09 |
08:00 |
| Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 |
Globe Newswire |
03/09 |
08:00 |
| electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 |
Globe Newswire |
03/09 |
08:00 |
| Signing Day Sports Highlights BlockchAIn’s Modular AI Data Center Strategy and Strategic Electrical Infrastructure Collaboration with PDM |
Globe Newswire |
03/09 |
08:00 |
| New American Drone and Defense Company to be Created Through Merger of Powerus and Aureus Greenway Holdings |
Globe Newswire |
03/09 |
08:00 |
| Deep Isolation Leadership to Present Innovations in Nuclear Waste Disposal at Waste Management 2026 in Phoenix, Arizona |
Globe Newswire |
03/09 |
08:00 |
| BeautyHealth Expands Skin Health Ecosystem with Growing Adoption of SkinStylus Nano-Channeling, a Popular Pairing with Hydrafacial Treatments |
Globe Newswire |
03/09 |
08:00 |
| Terra Innovatum Secures Nuclear-Grade Graphite Order with Mersen, Advancing SOLO™ FOAK Deployment and Commercialization Readiness |
Globe Newswire |
03/09 |
08:00 |
| First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment |
Globe Newswire |
03/09 |
08:00 |
